Access the full text.
Sign up today, get DeepDyve free for 14 days.
Nicky Karsdorp, Arthur Elderson, Dienke Wittebol-Post, Ronald Hené, Jaap Vos, Michiel Feldberg, Adriaan Gils, J. Veen, Thea Vroom, Jo Höppener, Cornelis Lips (1994)
Von Hippel-Lindau disease: new strategies in early detection and treatment.The American journal of medicine, 97 2
Taylor Jarrell, Edward Oldfield, R. Lonser (1991)
von Hippel-Lindau diseaseThe Lancet, 337
A. Kroiss, D. Putzer, C. Uprimny, C. Decristoforo, M. Gabriel, W. Santner, C. Kranewitter, B. Warwitz, D. Waitz, D. Kendler, I. Virgolini (2011)
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarificationEuropean Journal of Nuclear Medicine and Molecular Imaging, 39
V. Ambrosini, D. Campana, V. Allegri, G. Opocher, S. Fanti (2011)
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.Clinical nuclear medicine, 36 1
K. Melmon, S. Rosen (1964)
LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.The American journal of medicine, 36
R. Leung, S. Biswas, M. Duncan, S. Rankin (2008)
Imaging features of von Hippel-Lindau disease.Radiographics : a review publication of the Radiological Society of North America, Inc, 28 1
F. Latif, K. Tory, J. Gnarra, M. Yao, F. Duh, M. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil (1993)
Identification of the von Hippel-Lindau disease tumor suppressor gene.Science, 260 5112
A. Kroiss, D. Putzer, C. Uprimny, C. Decristoforo, M. Gabriel, W. Santner, C. Kranewitter, B. Warwitz, D. Waitz, D. Kendler, I. Virgolini (2010)
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidineEuropean Journal of Nuclear Medicine and Molecular Imaging, 38
V. Prasad, V. Ambrosini, A. Alavi, S. Fanti, R. Baum (2008)
PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism.PET clinics, 3 3
Priya Kaji, J. Carrasquillo, W. Linehan, Clara Chen, G. Eisenhofer, Peter Pinto, E. Lai, K. Pacak (2007)
The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.European journal of endocrinology, 156 4
E. Woodward, E. Maher (2006)
Von Hippel-Lindau disease and endocrine tumour susceptibility.Endocrine-related cancer, 13 2
Frederik Hes, Michiel Feldberg (1999)
Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses)European Radiology, 9
B. Seizinger, G. Rouleau, L. Ozelius, A. Lane, G. Farmer, J. Lamiell, J. Haines, J. Yuen, D. Collins, D. Majoor-Krakauer, T. Bonner, C. Mathew, A. Rubenstein, J. Halperin, A. McConkie-Rosell, J. Green, J. Trofatter, B. Ponder, L. Eierman, M. Bowmer, R. Schimke, B. Oostra, N. Aronin, David Smith, H. Drabkin, M. Waziri, W. Hobbs, R. Martuza, P. Conneally, Y. Hsia, J. Gusella (1988)
Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 332
M. Davenport, E. Caoili, R. Cohan, Carrie Hoff, J. Ellis (2010)
Pancreatic Manifestations of von Hippel-Lindau Disease-Effect of Imaging on Clinical ManagementJournal of Computer Assisted Tomography, 34
J. Kok, M. Lin, V. Wong, Peter Campbell, P. Lin (2009)
[18F]FDG PET/CT in pancreatic neuroendocrine tumours associated with von Hippel Lindau SyndromeClinical Endocrinology, 70
V. Rufini, M. Calcagni, R. Baum (2006)
Imaging of neuroendocrine tumors.Seminars in nuclear medicine, 36 3
H. Marcos, S. Libutti, H. Alexander, I. Lubensky, D. Bartlett, M. Walther, W. Linehan, G. Glenn, P. Choyke (2002)
Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.Radiology, 225 3
Von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome with a variety of benign and malignant tumors such as retinal and central nervous system hemangioblastomas, endolymphatic sac tumors, renal cysts and tumors, pancreatic cysts and tumors, pheochromocytomas, and epididymal cystadenomas. Cross-sectional modalities (computed tomography and magnetic resonance imaging) as well as ultrasound play a major role in the initial evaluation and follow-up of the various manifestations of VHL disease. Ga-68-labeled somatostatin receptor analogs already have a significant role in the diagnosis, staging, and therapy management of neuroendocrine neoplasms and neural crest tumors. Herein, we report a case presenting a variety of malignancies in VHL and showing the usefulness of Ga-68 somatostatin receptor PET/CT as a one-stop-shop imaging modality in the management of VHL disease.
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Apr 27, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.